KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
The paper focuses on the cultural and creative industry in Hangzhou, Zhejiang province. It explains how the city is committed to establishing itself as a leading and highly integrated cultural and creative hub of China.
Related links
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Business Issues in China - This overview takes a general look at the China market, and gives key insights into new developments.
Location Studies - Investors can get a deeper understanding of China's cities to learn about the different business opportunities these regions provide.